Literature DB >> 16192622

Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system.

Graça M Dores, William F Anderson, Susan S Devesa.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16192622     DOI： 10.1200/JCO.2005.03.0395

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Mycosis fungoides and Sézary syndrome.

Authors:  Constanze Jonak; Julia Tittes; Patrick Manfred Brunner; Emmanuella Guenova
Journal:  J Dtsch Dermatol Ges       Date:  2021-09       Impact factor: 5.231

2.  Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study.

Authors:  Jae Ho Han; Young-Hyeh Ko; Yun Kyung Kang; Wan-Seop Kim; Yoon Jung Kim; Insun Kim; Hyun-Jung Kim; Soo Kee Min; Chan-Kum Park; Chan-Sik Park; Bong-Kyung Shin; Woo Ick Yang; Young-Ha Oh; Jong Sil Lee; Juhie Lee; Tae Hui Lee; Hyekyung Lee; Ho Jung Lee; Yoon Kyung Jeon; Hee Jeong Cha; Yoo-Duk Choi; Chul Woo Kim
Journal:  Korean J Pathol       Date:  2014-04-28

3.  Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma.

Authors:  Akimichi Morita; Chiharu Tateishi; Kyoko Ikumi; Daisuke Hayashi; Aya Nakada; Haruna Nishihara; Kan Torii; Emi Nishida; Daisuke Tsuruta
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-27

4.  Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma.

Authors:  Akimichi Morita; Chiharu Tateishi; Shinnosuke Muramatsu; Ryouji Kubo; Eri Yonezawa; Hiroshi Kato; Emi Nishida; Daisuke Tsuruta
Journal:  J Dermatol       Date:  2020-03-18       Impact factor: 4.005
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.